May 24, 2011 - Hologic Inc. announced the first nine U.S. cities for a series of evening events to introduce clinicians to the Selenia Dimensions 2-D/3-D breast tomosynthesis system and gain hands-on experience with this new technology.

May 23, 2011 – According to a report, radiation medicine promises to be an even more effective weapon in the battle against cancer and may ultimately prove to be useful in chronic pain and neurodegenerative disorders. The report is a compendium of the 2011 Future of Radiation Medicine symposium, sponsored by Elekta. During the symposium, leading researchers and clinicians discussed how the field of radiation medicine is rapidly changing.

May 23, 2011—Calypso Medical Technologies Inc., developer of GPS for the Body technology used for the precise tracking of cancerous tumors during radiation therapy, is exhibiting at the American Urological Association Annual Meeting (booth 4337) and will discuss recent clinical findings suggesting that the Calypso System can be used to more precisely deliver radiation in post-prostatectomy patients.

May 23, 2011 - The core technology of ViewRay Inc., a combination of magnetic resonance imaging (MRI) and radiotherapy technologies, has been issued landmark patents in the United States and Europe. ViewRay, a privately held medical device company, holds the exclusive worldwide license for the technology from the University of Florida. The cancer treatment technology was invented by company founder James F. Dempsey, Ph.D., while he was a member of the radiation oncology faculty at the University of Florida.

May 20, 2011 - Accuray Incorporated announced that 85 percent of European CyberKnife centers are performing prostate SBRT to treat localized prostate cancer. There is an increasing trend towards treating prostate cancer patients with a hypofractionated regimen.